Sarah Js Glickman 2seventy Bio, Inc. (TSVT) insider trading activity

Sarah Js Glickman is of 2seventy bio, Inc.. Currently has a direct ownership of 0 shares of TSVT, which is worth approximately $0. The most recent transaction as insider was on May 13, 2025, when has been sold 12,050 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Sarah JS Glickman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2025	SELL Sale (or disposition) back to the issuer	-	12,050 Reduced 43.58%	15,602 Common Stock
May 13 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	15,602 Reduced 100.0%	0 Common Stock
Jun 10 2024	BUY Grant, award, or other acquisition	-	12,050 Added 30.35%	27,652 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	8,400 Added 35.0%	15,602 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	4,200 Added 36.84%	7,202 Common Stock
Nov 11 2021	BUY Grant, award, or other acquisition	-	3,002 Added 50.0%	3,002 Common Stock

Also insider at

ATR

APTARGROUP, INC. Healthcare

Director

CRTO

Criteo S.A. Communication Services

Chief Financial Officer

BLUE

bluebird bio, Inc. Healthcare

Director

SJG